Date: Thursday, February 6 Time: 4:00 PM CET | 10:00 AM EST
Leaky containers can jeopardize patient safety and lead to costly recalls. Join other pharma leaders and discover how a holistic approach to container closure integrity can protect injectables, ensure compliance, and maintain product quality throughout the product's life cycle.
Fill out the form to register now!
Meet the Speaker
Constantin Hozsa
Constantin Hozsa is a project manager for formulation and process development at Siegfried's Hameln (Germany) based R&D-department.
As subject matter expert for container integrity (testing), he is also responsible for the introduction of new Container Closure Integrity Test (CCIT) systems and the development of new CCIT methods. Prior to joining Siegfried, Constantin has worked for more than ten years in the development of nanoparticulate drug delivery systems for small molecules and biologicals.
What you'll learn:
Container closure integrity (CCI) is an essential product quality attribute of injectables. Maintaining CCI prevents product contamination and degradation, as well as loss of sterility.
Designing modern pharmaceutical packaging that ensures CCI over a product's life cycle is challenging, especially in novel, complex biological products requiring extreme storage conditions. How can you meet these evolving demands?
Join Constantin Hozsa, R&D Project Manager, in a FREE webinar that uses vials as an example to dive into the critical role of CCI and CCI testing in pharmaceutical packaging and answers key questions:
